Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus (Q43162911)
Jump to navigation
Jump to search
scientific article published on 19 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus |
scientific article published on 19 November 2015 |
Statements
1 reference
Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus (English)
1 reference
1 reference
Shirong Qiang
1 reference
Yusuke Nakatsu
1 reference
Yasuyuki Seno
1 reference
Midori Fujishiro
1 reference
Hideyuki Sakoda
1 reference
Keiichi Mori
1 reference
Yasuka Matsunaga
1 reference
Takeshi Yamamotoya
1 reference
Hideaki Kamata
1 reference
Tomoichiro Asano
1 reference
19 November 2015
1 reference
1 reference
Identifiers
1 reference